D70.2 – Other drug-induced agranulocytosis

ICD-10-CM 2027 diagnosis code · Other disorders of blood and blood-forming organs

Billable code

ICD-10-CM code D70.2
Code
D70.2 (claims format: D702)
Description
Other drug-induced agranulocytosis
Billable
Yes – valid for HIPAA-covered transactions
Valid for
Dates of service October 1, 2026 – September 30, 2027 (FY2027)
Chapter
3. Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89)
Block
D70-D77 Other disorders of blood and blood-forming organs
Parent codes
D70

Notes for D70.2

Use additional code:
  • code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)

Notes inherited from parent codes

Instructional notes at a category or block level apply to every code below it.

D70 – Neutropenia

Includes:
  • agranulocytosis
  • decreased absolute neurophile count (ANC)
Excludes1 (not coded here):
  • neutropenic splenomegaly (D73.81)
  • transient neonatal neutropenia (P61.5)
Use additional code:
  • code for any associated:
  • fever (R50.81)
Code also:

Index terms for D70.2

Entries in the ICD-10-CM alphabetic index that lead to this code:

Related codes in D70

Frequently asked questions

What is ICD-10 code D70.2?

D70.2 is the ICD-10-CM code for other drug-induced agranulocytosis, in the block D70-D77 (Other disorders of blood and blood-forming organs).

Is D70.2 a billable code?

Yes. D70.2 is a billable/specific code that can be used to indicate a diagnosis for reimbursement purposes.

What category does D70.2 belong to?

It belongs to category D70 – Neutropenia.

Source: CDC/NCHS ICD-10-CM FY2027 code files, tabular list and index. Reference only – code assignment must follow the official ICD-10-CM guidelines and documentation in the medical record.